# DataJoint

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/datajoint

- Industry: Software
- Headquarters: Houston, US
- Website: www.datajoint.com
- Total disclosed funding: $4.9M
- Latest round: Seed (Sep 30, 2025)
- Investors on record: 3

## About

DataJoint, headquartered in Houston, US, is dedicated to providing an integrated platform that streamlines data management for the scientific community. Their solutions enhance research efficiency and support complex workflows across various fields.DataJoint, founded in 2016, focuses on automating workflows for scientific research. The company has not undergone any publicly noted pivots or changes in strategy. It does not have any parent or subsidiary companies. DataJoint was established by a team of individuals with expertise in data science and research. The company has completed one deal since its inception, with its most recent funding round taking place in September 2025 when it raised USD 4.9 million in a SEED round, co-led by investors including Capital Factory, Inoca Capital Partners, and Nina Capital. The total amount raised by DataJoint amounts to USD 4.9 million.DataJoint specializes in providing a comprehensive platform designed to integrate instruments, code, data, and computation into automated workflows tailored for the scientific community. Their core offerings focus on enhancing research efficiency by creating structured, transparent, and reproducible processes that are AI-ready. This functionality is particularly valuable for research teams dealing with complex data management, such as in neuroscience, oncology, and biomedical fields. DataJoint's solutions cater to prestigious research institutions and laboratories worldwide, helping them streamline data operations and improve the quality and accessibility of their research outputs. The platform is geared towards researchers who require robust data management tools to ensure that their experiments and findings stand up to scrutiny and are easily interpretable, thus supporting broader scientific collaboration and innovation.DataJoint generates revenue primarily through subscription-based models and partnerships with research institutions. Clients typically engage with the platform by subscribing to its services, which include access to the software for organizing and managing research data. These subscriptions are structured to accommodate various user needs, allowing labs to choose plans that fit their operational scale. This model includes tiered pricing that aligns with the specific features and tools utilized within the platform. DataJoint's flagship offerings support extensive data integration and workflow automation, delivering significant time savings and efficiency improvements for research teams, ultimately enhancing the value proposition for its client base.In September 2025, DataJoint raised USD 4.9 million in SEED funding, which will be used to scale its operations, enhance its proprietary SaaS platform, and expand its market reach to commercial life sciences and pharmaceutical companies in the United States and Europe. The company is planning to introduce new products aimed at further improving data integration and automation features, although specific release dates have not been disclosed.

## Funding rounds

- Seed, Sep 30, 2025, $4.9M — Capital Factory, Inoca Capital Partners, Nina Capital

## Investors

- Capital Factory (https://capitalatlas.ai/funds/capital-factory) — Seed
- Inoca Capital Partners (https://capitalatlas.ai/funds/inoca-capital-partners) — Seed
- Nina Capital (https://capitalatlas.ai/funds/nina-capital) — Seed